Balchem Corp: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über Balchem Corp Unternehmen

Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Balchem Corp Informationen



BörsenkürzelBCPC

Name des UnternehmensBalchem Corp

IPO-datumJun 03, 1986

CEOHarris (Theodore L)

Anzahl der mitarbeiter1361

WertpapierartOrdinary Share

GeschäftsjahresendeJun 03

Addresse- -

Stadt- -

BörseNASDAQ OMX - NASDAQ BASIC

Land- -

Postleitzahl- -

Telefon- -

Website- -

BörsenkürzelBCPC

IPO-datumJun 03, 1986

CEOHarris (Theodore L)

Führungskräfte von Balchem Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Theodore L. (Ted) Harris

Chairman of the Board, President, Chief Executive Officer

61.58K

-478.00%

Mr. David B. (Dave) Fischer

Independent Director

5.94K

-2000.00%

Ms. Hatsuki Miyata

Executive Vice President, Chief Legal Officer and Secretary

1.55K

-483.00%

Mr. Frederic Boned

Senior Vice President, General Manager - Human Nutrition and Health

410.00

-1456.00%

Mr. Matthew D. (Matt) Wineinger

Lead Independent Director

--

Mr. Daniel E. Knutson, CPA

Independent Director

--

Mr. C. Martin Bengtsson

Chief Financial Officer, Executive Vice President

--

Ms. Kathleen B. Fish

Independent Director

--

Mr. Martin L. Reid

Senior Vice President and Chief Supply Chain Officer

--

Mr. Olivier Rigaud

Independent Director

--

-1520.00%

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Theodore L. (Ted) Harris

Chairman of the Board, President, Chief Executive Officer

61.58K

-478.00%

Mr. David B. (Dave) Fischer

Independent Director

5.94K

-2000.00%

Ms. Hatsuki Miyata

Executive Vice President, Chief Legal Officer and Secretary

1.55K

-483.00%

Mr. Frederic Boned

Senior Vice President, General Manager - Human Nutrition and Health

410.00

-1456.00%

Mr. Matthew D. (Matt) Wineinger

Lead Independent Director

--

Mr. Daniel E. Knutson, CPA

Independent Director

--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product Sales Revenue

267.08M

99.82%

Royalty

480.00K

0.18%

Nach RegionUSD

Name

Umsatz

Anteil

United States

198.06M

74.03%

Foreign Countries

69.49M

25.97%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Product Sales Revenue

267.08M

99.82%

Royalty

480.00K

0.18%

Aktionärsstatistik

Aktualisiert: Sun, Jan 11

Aktionäre

Aktionärstypen

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

13.43%

The Vanguard Group, Inc.

11.95%

Conestoga Capital Advisors, LLC

3.72%

State Street Investment Management (US)

3.71%

Wasatch Global Investors Inc

3.34%

Andere

63.86%

Aktionäre

Anteil

BlackRock Institutional Trust Company, N.A.

13.43%

The Vanguard Group, Inc.

11.95%

Conestoga Capital Advisors, LLC

3.72%

State Street Investment Management (US)

3.71%

Wasatch Global Investors Inc

3.34%

Andere

63.86%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

50.63%

Investment Advisor/Hedge Fund

28.49%

Hedge Fund

5.93%

Pension Fund

2.43%

Research Firm

1.95%

Sovereign Wealth Fund

1.59%

Bank and Trust

1.14%

Individual Investor

0.54%

Family Office

0.13%

Andere

7.16%

Institutionelle Beteiligung



Aktualisiert: Mon, Dec 8

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q4

692

30.08M

92.73%

+17.89K

2025Q3

707

30.06M

92.66%

+267.74K

2025Q2

685

29.78M

92.71%

+58.29K

2025Q1

661

29.74M

93.11%

-556.18K

2024Q4

638

29.76M

94.56%

+6.32K

2024Q3

611

29.83M

94.33%

+196.23K

2024Q2

600

29.66M

94.99%

-187.86K

2024Q1

588

29.84M

94.20%

-559.06K

2023Q4

578

29.57M

93.53%

+265.95K

2023Q3

565

29.33M

93.21%

-102.61K

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

BlackRock Institutional Trust Company, N.A.

4.35M

13.43%

-88.58K

-2.00%

Sep 30, 2025

The Vanguard Group, Inc.

3.89M

12%

-4.23K

-0.11%

Sep 30, 2025

Conestoga Capital Advisors, LLC

1.27M

3.93%

+125.41K

+10.93%

Sep 30, 2025

State Street Investment Management (US)

1.20M

3.71%

-25.05K

-2.04%

Sep 30, 2025

Wasatch Global Investors Inc

1.08M

3.34%

+121.15K

+12.62%

Sep 30, 2025

Geode Capital Management, L.L.C.

995.83K

3.07%

+14.86K

+1.51%

Sep 30, 2025

Geneva Capital Management LLC

987.98K

3.05%

+92.45K

+10.32%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

579.05K

1.79%

+3.65K

+0.64%

Sep 30, 2025

Norges Bank Investment Management (NBIM)

469.08K

1.45%

+38.60K

+8.97%

Jun 30, 2025

JP Morgan Asset Management

459.75K

1.42%

+70.70K

+18.17%

Sep 30, 2025

Verbundene ETFs



Aktualisiert: Sat, Dec 6

Name

Anteil

Invesco S&P SmallCap Materials ETF

6.89%

Invesco S&P SmallCap Quality ETF

1.2%

First Trust Horizon Managed Vol Small/Mid ETF

1.05%

ProShares Russell 2000 Dividend Growers ETF

0.91%

Invesco S&P SmallCap Low Volatility ETF

0.87%

State Street SPDR S&P 600 Small Cap Growth ETF

0.68%

Vanguard S&P Small-Cap 600 Growth Index Fund

0.64%

iShares S&P Small-Cap 600 Growth ETF

0.63%

Pacer US Small Cap Cash Cows Growth Leaders ETF

0.57%

Parametric Equity Premium Income ETF

0.56%

Invesco S&P SmallCap Materials ETF

Anteil6.89%

Invesco S&P SmallCap Quality ETF

Anteil1.2%

First Trust Horizon Managed Vol Small/Mid ETF

Anteil1.05%

ProShares Russell 2000 Dividend Growers ETF

Anteil0.91%

Invesco S&P SmallCap Low Volatility ETF

Anteil0.87%

State Street SPDR S&P 600 Small Cap Growth ETF

Anteil0.68%

Vanguard S&P Small-Cap 600 Growth Index Fund

Anteil0.64%

iShares S&P Small-Cap 600 Growth ETF

Anteil0.63%

Pacer US Small Cap Cash Cows Growth Leaders ETF

Anteil0.57%

Parametric Equity Premium Income ETF

Anteil0.56%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 87.88M USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Dec 10, 2025

BCPC.NB Final Cash Dividend of gross USD 0.96 paid on Jan 20, 2026 going ex on Dec 23, 2025

Dec 23, 2025

Jan 20, 2026

Dec 23, 2025

Dec 10, 2024

BCPC.NB Final Cash Dividend of gross USD 0.87 paid on Jan 17, 2025 going ex on Dec 26, 2024

Dec 26, 2024

Jan 17, 2025

Dec 26, 2024

Dec 05, 2023

BCPC.NB Final Cash Dividend of gross USD 0.79 paid on Jan 19, 2024 going ex on Dec 26, 2023

Dec 27, 2023

Jan 19, 2024

Dec 26, 2023

Dec 06, 2022

BCPC.NB Final Cash Dividend of gross USD 0.71 paid on Jan 20, 2023 going ex on Dec 23, 2022

Dec 27, 2022

Jan 20, 2023

Dec 23, 2022

Dec 16, 2021

BCPC.NB Final Cash Dividend of gross USD 0.64 paid on Jan 21, 2022 going ex on Dec 27, 2021

Dec 28, 2021

Jan 21, 2022

Dec 27, 2021

Dec 17, 2020

BCPC.NB Final Cash Dividend of gross USD 0.58 paid on Jan 22, 2021 going ex on Dec 24, 2020

Dec 28, 2020

Jan 22, 2021

Dec 24, 2020

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten